Portugal
PwC advises IVC Evidence in two acquisitions
Publication: ECO
Author: Filipa Ambrósio de Sousa
Source published: 18/11/2026, 13:25:01 UTC
Briefing created: 18/11/2026, 14:23:40 UTC
Based on a feed excerpt; full article content has not been acquired. Source evidence retrieved 18/11/2026, 13:26:24 UTC.
Briefings
PwC Portugal completed nine M&A transactions in Portugal since July 2025, including two major acquisitions of IVC Evidensia: the Hospital Veterinario do Baixo Alentejo in Beja and the HVB Hospital Veterinario de Braga. Legal, labor, real estate, public law, and financial due diligence teams led by senior professionals conducted due diligence and negotiated legal documentation for these deals. PwC increased its revenue in Portugal to nearly 230 million euros. The evidence covers the period from July 2025 to November 2026, with specific dates and personnel details provided.
Key points
- PwC Portugal completed nine M&A transactions in Portugal since July 2025, including two major acquisitions of IVC Evidensia: the Hospital Veterinario do Baixo Alentejo in Beja and the HVB Hospital Veterinario de Braga.
- The legal team led by Luís Pedro Oliveira coordinated due diligence and transaction negotiations for both IVC Evidensia acquisitions, while the financial due diligence team led by Ana Silva handled the specific acquisition of the Hospital Veterinario do Baixo Alentejo in Beja.
Context
PwC assessors IVC Evidensia, a British-Swiss veterinary care group, completed two major acquisitions in Portugal: the Hospital Veterinario do Baixo Alentejo in Beja and the HVB Hospital Veterinario de Braga. These operations strengthen IVC Evidensia's presence in the Portuguese market and add to the support PwC has provided to the group since July 2025, with nine transactions concluded in total.
Limitations
The evidence covers the period from July 2025 to November 2026, with specific dates and personnel details provided. The evidence does not include information about the financial impact of the acquisitions beyond the revenue increase, nor does it contain details about the future performance or long-term strategic implications of the IVC Evidensia acquisitions.
Generated by Bittrees-hosted qwen35-2b sha256:aaf42c8b7c3c on 18/11/2026, 14:23:40 UTC. Based on publisher-provided feed evidence; may not cover the full original article. Check the source for details.
View archived briefing on IPFS
bafybeif47wvdezs2u5vxk5koqvui5z2hga2nikc7lp7wjv7flcjyzbe5vq